Mycobacterium haemophilum: Microbiology and expanding clinical and geographic spectra of disease in humans

Clinical Microbiology Reviews

Volumn 9, Issue 4, 1996, Pages 435-447

  Saubolle, Michael A ^a,c   Kiehn, Timothy E ^d   White, Mary H ^d   Rudinsky, Mark F ^b   Armstrong, Donald ^d  

^a BANNER GOOD SAMARITAN MEDICAL CENTER   (United States)

^b PHOENIX CHILDREN'S HOSPITAL   (United States)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOSALICYLIC ACID; CIPROFLOXACIN; CLARITHROMYCIN; COTRIMOXAZOLE; CYCLOSERINE; DICLOXACILLIN; DOXYCYCLINE; ERYTHROMYCIN; ETHAMBUTOL; FERRIC AMMONIUM CITRATE; HEMIN; ISONIAZID; MINOCYCLINE; OFLOXACIN; PYRAZINAMIDE; RIFABUTIN; RIFAMPICIN; STREPTOMYCIN; SULFAMETHOXAZOLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BACTERIAL ARTHRITIS; BACTERIAL INFECTION; BACTERIUM ISOLATION; BONE MARROW HYPOPLASIA; BONE MARROW TRANSPLANTATION; CROHN DISEASE; EARLY DIAGNOSIS; HEART TRANSPLANTATION; HUMAN; IMMUNE DEFICIENCY; IMMUNOCOMPETENCE; KIDNEY TRANSPLANTATION; LYMPHADENITIS; LYMPHOMA; MYCOBACTERIUM HAEMOPHILUM; OSTEOMYELITIS; PNEUMONIA; REVIEW; RHEUMATOID ARTHRITIS; SKIN INFECTION; SYMPTOM; SYSTEMIC DISEASE; TEMPERATURE; TREATMENT OUTCOME;

BACTERIA (MICROORGANISMS); MYCOBACTERIUM HAEMOPHILUM;

EID: 0029921981     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/cmr.9.4.435-447.1996     Document Type: Review

References (56)

1. Abbott, M. R., and D. D. Smith. 1980. The pathogenic effects of Mycobacterium haemophilum in immunosuppressed albino mice. J. Med. Microbiol. 13:535-540.
2. Abbott, M. R., and D. D. Smith. 1981. Mycobacterial infections in immunosuppressed patients. Med. J. Aust 1:351-353.
3. Abell, F., and P. B. Harrison. 1994. Mycobacterium haemophitum infection in an elderly patient. Aust. N. Z. J. Med. 24:404.
4. Armstrong, K. L., R. W. James, D. J. Dawson, P. W. Francis, and B. Masters. 1992. Mycobactaium haemophilium causing perihilar or cervical lymphadenitis in healthy children. J. Pediatr. 121:202-205.
5. Artenstein, A. W., D. Fritzinger, R. A. Gasser, Jr., L. P. Skillman, P. L. McEvoy, and T. L. Hadfield. 1994. Infection dne to Mycobacterium haemophilum identified by whole cell lipid analysis and nucleic acid sequencing. Clin. Infect Dis. 19:1155-1157.
6. Becherer, P., and S. L Hopfer. 1992. Infection with Mycobacterium haemophiium. Clin. Infect. Dis. 14:793.
7. Bernard, E. M, F. F. Edwards, T. E. Kiehn, S. T. Brown, and D. Armstrong. 1993. Activities of antimicrobial agents against clinical isolates of Mycobacterium haemophilum. Antimicrob. Agents Chemother. 37:2523-2326.
8. Besra, G. S, M. McNeil, D. E. Minnikin, F. Portaels, M. Ridell, and P. J. Brennan. 1991. Structural elucidation and antigenicity of a novel glycolipid antigen from Mycobacterium haemophilum. Biochemistry 30:7772-7777.
9. Branger, B., A, Gouby, R. Oules, J. P. Balduechi, G. Mourard, J. Fourcade, C. Mion, F. Dnntz, and M. Ramuz. 1985. Mycobacterium haemophilum and Mycobacterium xenopi associated infection in a renal transplant patient Clin. Nephrol. 23:46-49.
10. Cage, G. D. 1994. Direct identification of Mycobacterium species in BACTEC 7H12B medium by high-performance liquid chromatography. J. Clin. Microbiol. 32:521-524.
11. Centers for Disease Control. 1991. Mycobacterium haemophilum infections - New York City metropolitan area, 1990-1991. Morbid. Mortal. Weekly Rep. 40:636-637, 643.
12. Cooper, D. K. C., R. P. Lanza, S. Oliver, A. A. Forder, A. G. Rose, C. J. Uys, D. Novitsky, and C. N. Barnard. 1983. Infectious complications after heart transplantation. Thorax 38:822-828.
13. Damato, J. J., and M. T. Collins. 1984. Radiometric studies with gas-liquid and thin-layer chromatography for rapid demonstration of hemin dependence and characterization of Mycobacterium haemophilum. J. Clin. Microbiol. 20:515-518.
14. Darling, T. N, N. Sidhu-Malik, G. R. Corey, N. B. Allen, H. Kamino, and M. C. Murray. 1994. Treatment of Mycobacterium haemophilum infection with an antibiotic regimen including clarithromycin. Br. J. Dermatol. 131: 376-379.
15. Davis, B. R., J. Brumbach, W. J. Sanders, and E. Wolinsky. 1982. Skin lesions caused by Mycobacterium haemophilum. Ann. Intern. Med. 97:723-724.
16. Dawson, D. J., Z. M. Blacklock, and D. W. Kane. 1981. Mycobacterium haemophilum causing lymphadenitis in an otherwise healthy child. Med. J. Aust. 2:389-290.
17. Dawson, D. J., and F. Jennis. 1980. Mycobacteria with a growth requirement for ferric ammonium citrate, identified as Mycobacterium haemophilum. J. Clin. Microbiol. 11:190-192.
18. Dever, L. L., J. W. Martin, B. Seaworth, and J. H. Jorgensen. 1992. Varied presentations and responses to treatment of infections caused by Mycobacterium haemophilum in patients with AIDS. Clin. Infect Dis. 14:1195-1200.
19. Feldman, R. A., and E. Hershfield. 1974. Mycobacterial skin infection by an unidentified species: a report of 29 patients. Ann. Intern. Med. 86:445-452.
20. Fischer, L. J., F. D. Quinn, E. H. White, and C. H. King. 1996. Intracellular growth and cytotoxicity of Mycobacterium haemophilum in human epithelial cell line (Hec-1-B). Infect. Immun. 64:269-276.
21. Gouby, A., B. Branger, R. Oules, and M. Ramuz. 1988. Two cases of Mycobacterium haemophilum infection in a renal-dialysis unit. J. Med. Microbiol. 25:299-300.
22. Gupta, L, J. Kocher, A. J. Miller, S. J. Weisholtz, J. Perz, and M. Scully. 1992. Mycobacterium haemophilium osteomyelitis in an AIDS patient. N. J. Med. 89:201-202.
23. Heifets, L. B. 1991. Dilemmas and realities in drug susceptibility testing of M avium-M. intracellulare and other slowly growing nontuberculous mycobacteria, p. 123-146. In L. B. Heifets (ed.), Drug susceptibility in the chemotherapy of mycobacterial infections. CRC Press, Inc., Boca Raton, Fla.
24. Holton, J., P. Nye, and R. Miller. 1991. Mycobacterium haemophilum infection in a patient with AIDS. J. Infect. 23:303-306.
25. Kiehn, T. E. Unpublished data
26. Kiehn, T. E., and M. White. 1994. Mycobacterium haemophilum: an emerging pathogen. Eur. J. Clin. Microbiol. Infect Dis. 13:925-931.
27. Kiehn, T. E., M. White, K. J. Pursell, N. Boone, M. Tsivitis A. E. Brown, B. Poisky, and D. Armstrong. 1993. A cluster of four cases of Mycobacterium haemophilum infection. Eur. J. Clin. Microbiol. Infect. Dis. 12:114-118.
28. Kikuchi, K., E. M. Bernard, T. E, Kiehn, D. Armstrong, and L. W. Riley. 1994. Restriction fragment length polymorphism analysis of clinical isolates of Mycobacterium haemophilum. J. Clin. Microbiol. 32:1703-1767.
29. Kristjansson, M., V. M. Bieluch, and P. D. Byeff. 1991. Mycobacterium haemophilum infection in immunocompromised patients: case report and review of the literature. Rev. Infect. Dis. 13:906-910.
30. Lederman, C., J. L. Spitz, B. Scully, L. L. Schulman, P. Della-Latta, I. Weitzman, and M. E. Grossman. 1994. Mycobacterium haemophilum cellulitis in a heart transplant recipient J. Am. Acad. Dermatol. 36:804-805.
31. Lerner, G. W., A. Safdar, and S. Coppel. 1995. Mycobacterium haemophilum infection in AIDS. Infect. Dis. Clin. Pract. 4:233-236.
32. Lomvardias, S., and G. E. Madge. 1972 Chaetoconidium: and atypical acid-fast bacilli in skin ulcers. Arch. Dermatol. 106:875-876.
33. Males, B. M., T. E. West, and W. R. Bartholomew. 1987. Mycobacterium haemophilum infection in a patient with acquired immune deficiency syndrome. J. Clin. Microbiol. 25:386-190.
34. McBride, J. E., M. E. McBride, and L E. Wolf, Jr. 1992, Evaluation of commercial blood containing media for cultivation of Mycobacterium haemophilum. Am. J. Clin. Pathol. 98:282-286.
35. McBride, M. E., A. H. Rudolph, J. A. Tschen, P. Cernoch, J, Davis, B. A. Brown, and R. J. Wallace. 1991. Diagnostic and therapeutic considerations for cutaneous Mycobacterium haemophilum infections. Arch. Dermatol. 127: 276-277. (Letter.)
36. McGovern, J., B. C. Bix, and G. W. Webster. 1994. Mycobacterium haemophilum skin disease successfully treated with excision. J. Am. Acad. Dermatol. 30:269-270.
37. Mezo, A., F. Jennis, S. W. McCarthy, et al. 1979. Unusual mycobacteria in 5 cases of opportunistic infections. Pathology 11:377-384.
38. Moulsdale, M. T., J. M. Harper, and G. N. Thatcher. 1983. Infection by Mycobacterium haemophilum, a metabolically fastidious acid-fast bacillus. Tubercle 64;29-36.
39. Portaels, F., D. J. Dawson, L. Larsson, and L Rigouts. 1993. Biochemical properties and fatty acid composition of Mycobacterium haemophilum: study of 16 isolates from Australian patients. J. Clin. Microbiol. 31:26-30.
40. Rogers, P. L., R. E. Walker, H. C. Lane, F. G. Witebsky, J. A. Kovacs, J. E. Parrillo, and H. Masur. 1988. Disseminated Mycobacterium haemophailum infection in two patients with the acquired immunodeficiency syndrome. Am. J. Med. 84:640-642.
41. Ryan, C. G., and B. W. Dwyer. 1983. New characteristics of Mycobacterium haemophilum. J. Clin. Microbiol. 18:976-977.
42. Sompolinsky, D., A. Lagziel, D. Naveh, and T. Yankileritz. 1978. Mycobacterium haemophilum sp. nov., a new pathogen of humans, Int. J. Syst. Bacteriol 28:67-75.
43. Sompolinsky, D., A. Lagziel, and I. Rosenberg, 1979. Further studies of a new pathogenic mycobacterium (M. haemophilum sp. nov.). Can. J. Microbiol. 25:217-226.
44. Soubani, A. O, A. Mohammed, and S. Forlenza. 1994. Successful treatment of disseminated Mycobacterium haemophilum infection in a patient with AIDS. Clin. Infect. Dis. 18;475.
45. Sowden, D., R. Kemp, and D. Dawson. 1993. Osteomyelitis due to Mycobacterium haemophilum in a patient with AIDS. Pathology 25:308-309.
46. Straus, W. L., S. M. Ostroff, D.B. Jernigan, T. E. Kiehn, E. M. Sordillo, D. Armstrong, N. Boone, N. Schneider, J. O. Kilburn, V. A. Silcox, V. LaBombardi, and R. C Good. 1994. Clinical and epidemiologic characteristics of Mycobacterium haemophilum, an emerging pathogen in immunocompromised patients. Ann. Intern. Med. 120:118-125.
47. Thibert, L., and S. Lapierre. 1993. Routine application of high-performance liquid chromatography for identification of mycobacteria. J. Clin. Microbiol. 31:1759-1763.
48. Thibert, I., F. Iebel, and B. Martinean. 1990. Two cases of Mycobacterium haemophäum infection in Canada. J. Clin. Microbiol. 28:621-623.
49. Vadney, F. S., and J. E. Hawkins. 1985. Evaluation of a simple method for growing Mycobacterium haemophilum. J. Clin. Microbiol. 22:884-885.
50. Walder, B. K., D. Jererny, A. Charleswerth, G. J. MacDonald, B. A. Pussel, and M. R. Robertson. 1976. The skin and immunosuppression. Aust. J. Dermatol. 17:94-97.
51. Wayne, L. G., and G. P. Kubica. 1986. Mycobacteria, p. 1436-1457. In P. H. A. Sneath, N. S. Mair, M. E. Sharpe, and J. G. Holt (ed.), Bergey's manual of systematic bacteriology, vol. 2. The Williams & Wilkins Co., Baltimore.
52. Wayne, L. G., and H. A. Sramek. 1992. Agents of newly recognized or infrequently encountered mycobacterial diseases. Clin. Microbiol. Rev. 5:1-25.
53. White, M.H., E. Papadopoulos, T. N. Small, T. E. Kiehn, and D. Armstrong. 1995. Mycobacterium haemophilum infections in bone marrow transplant recipients. Transplantation 60:957-960.
54. White, M. P., H. Bangash, K. M. Goel, and P. A. Jenkins. 1986. Non-tuberculous mycobacterial lymphadenitis. Arch. Dis. Child. 61:368-371.
55. Yakrus, M. A, and W. L. Straus. 1994. DNA polymorphisms detected in Mycobacterium haemophilum by pulsed-field gel electrophoresis, J. Clin. Microbiol. 32:1083-1084.
56. Yarrish, R. L, W. Shay, V. J. LaBombardi, M. Meyerson, D. K. Miller, and D. Larone. 1992. Osteomyelitis caused by Mycobacterium haemophilum: successful therapy in two patients with AIDS. AIDS 6:557-561.